Abstract
Menopause refers to the cessation of menstruation. Menopause brings about a deficiency of estrogen and a period of bone loss that extends till the end of life and is responsible for development of osteoporotic fractures in women. Prevention of vertebral fractures, non-vertebral fractures and hip fractures in post-menopausal women can be effectively done by Hormone Replacement Therapy (HRT) as it prevents bone loss following menopause and can delay development of osteoporosis as seen on DEXA scan. HRT use however is associated with the risk of cardiovascular disease, dementia, genito-urinary problems, breast, endometrial and ovarian cancer and the risk of venous thromboembolism. However in selected postmenopausal women with early menopause or with postmenopausal symptoms short-term use of HRT/Raloxifene/Tibolone is currently permitted to alleviate symptoms.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Orthopedics, Traumatology and Rehabilitation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
